Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 486

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Intermediate Filament Proteins and Their Associated Diseases

Open access
Omary, M. Bishr, Coulombe, Pierre A., McLean, W.H. Irwin·2004·New England Journal of Medicine

Abstract

he cytoskeleton consists of three abundant families of fibrillary proteins: microfilaments, microtubules, and intermediate filaments.1,2 Intermediate filament proteins derive their name from their diameter, which is intermediate between the diameters of microfilaments and microtubules.1,2 They differ from actin microfilaments and tubulin microtubules in their large number, their distribution in the cytoplasm and nucleus, their diverse primary structure (Table 1), their nonpolar architecture, their relative insolubility, and their nucleotide-independent dynamics.[1][2][3] The human genome contains at least 65 functional genes encoding intermediate filament proteins, placing them among the 100 largest gene families in humans.4 More than 30 diseases are related to mutations in these genes (Table 2).The majority of them are rare (affecting fewer than 200,000 patients in the United States) or difficult to treat, 7 but collectively they affect most tissues, and not all of them are rare, as exemplified by the association of keratin mutations with end-stage liver disease.Intermediate filament proteins have long been considered unique to multicellular eukaryotic organisms, 8 in contrast to microfilaments and microtubules, which have prokaryotic ancestors.However, crescentin, which is found in several curved bacteria, including Caulobacter crescentus and Helicobacter pylori, was recently identified as an intermediate filament-like ancestor protein that accounts for the morphologic features of caulobacter.9 structure All intermediate filament proteins have a prototypical structure consisting of a coiledcoil, a -helix rod domain (two polypeptide a -helixes wound around each other) that is interrupted by linkers and flanked by N-terminal head and C-terminal tail domains (Fig. 1).2,3 The simplest soluble unit of intermediate filament proteins is a tetramer consisting of two antiparallel dimers; each dimer, in the case of keratins, consists of one type I keratin molecule and one type II keratin molecule.A high-resolution architectural model of intermediate filaments is lacking, although the mature, 10-to-12-nm fiber is believed to contain 32 monomers in diameter, with important structural polymorphisms among members of the protein family.2,3 Cytoplasmic intermediate filaments can assume various network configurations depending on the cell type and manifest variable differentiation-related patterns, such as those in apical poles (e.g., pancreatic keratins), Z lines (desmin), and axonal processes (neurofilaments).2,3,10 regulation Intermediate filament proteins are regulated by several post-translational modifications, including farnesylation, phosphorylation, glycosylation, and transglutamination, t general features of intermediate filaments

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmra040319

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 486

Metadata

Authors
Omary, M. B., Coulombe, P. A., & McLean, W. H. I.
Venue
New England Journal of Medicine
Published
2004-11-11
Volume
351
Issue
20
Pages
2087-2100
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2049672237
Cited by
486
References
1
FWCI
12.82
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intermediate Filament Proteins and Their Associated Diseases. https://app.cochat.ai/papers/10.1056/nejmra040319
The paper
Omary, M. B., Coulombe, P. A., & McLean, W. H. I. (2004). Intermediate Filament Proteins and Their Associated Diseases. New England Journal of Medicine. https://doi.org/10.1056/nejmra040319

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.